ANI Pharmaceuticals Inc (ANIP) — Cash Flow Quality Index
ANI Pharmaceuticals Inc (ANIP) has a Cash Flow Quality Index of 1.10x as of December 2025. Operating cash flow of $30.37 Million exceeds net income of $27.49 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of ANI Pharmaceuticals Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ANI Pharmaceuticals Inc Cash Flow Quality Index (2006–2025)
Historical Cash Flow Quality Index for ANI Pharmaceuticals Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ANIP cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ANI Pharmaceuticals Inc (2006–2025)
Year-by-year earnings quality comparison for ANI Pharmaceuticals Inc. For live market cap and the full company financial profile, see ANI Pharmaceuticals Inc market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.36x | $185.22 Million | $78.34 Million | ▼ -62.7% |
| 2023 | 6.33x | $118.96 Million | $18.78 Million | ▼ -15.4% |
| 2019 | 7.49x | $45.63 Million | $6.09 Million | ▲ +73.0% |
| 2018 | 4.33x | $67.07 Million | $15.49 Million | ▼ -38.0% |
| 2016 | 6.98x | $27.47 Million | $3.93 Million | ▲ +521.9% |
| 2015 | 1.12x | $17.26 Million | $15.38 Million | ▲ +46.5% |
| 2014 | 0.77x | $22.03 Million | $28.75 Million | ▲ +104.2% |
| 2013 | -18.22x | $-5.48 Million | $301.00K | ▼ -917.8% |
| 2006 | -1.79x | $-5.00 Million | $2.79 Million | — |